<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04305847</url>
  </required_header>
  <id_info>
    <org_study_id>P/2020/480</org_study_id>
    <nct_id>NCT04305847</nct_id>
  </id_info>
  <brief_title>Satisfaction Assessment After Axillary Block</brief_title>
  <acronym>Qual'AXI</acronym>
  <official_title>Satisfaction Assessment After Axillary Brachial Plexus Block for Distal Arm Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Satisfaction assessment at 24 and 48 hours post operatively, after Axillary Brachial Plexus
      Block for Distal Arm Surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion after distal Arm Surgery performed under Axillary Brachial Plexus Block.

      Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey
      questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 9, 2020</start_date>
  <completion_date type="Anticipated">November 9, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 9, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evan-LR score on day 2</measure>
    <time_frame>at 48 hours postoperative</time_frame>
    <description>self administrated Evan-LR: &quot;Evaluation du Vécu de l'Anesthésie LocoRégionale&quot; 0-to-100 scale, with &quot;100&quot; indicating the best possible level of satisfaction and &quot;0&quot; the worst.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evan-LR score on day 1</measure>
    <time_frame>at 24 hours postoperative</time_frame>
    <description>self administrated Evan-LR: &quot;Evaluation du Vécu de l'Anesthésie LocoRégionale&quot; 0-to-100 scale, with &quot;100&quot; indicating the best possible level of satisfaction and &quot;0&quot; the worst.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Net Promotor score on day 2</measure>
    <time_frame>at 48 hours postoperative</time_frame>
    <description>self administrated Net Promotor score: willingness to advise a relative to undergo the same operation on a scale from 0 to 10. Based on the score, patients are divided into promoters (9 or 10), passives (7 or 8), and detractors (under 6). The NPS is determined as follows: NPS = % promoters - % detractors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Net Promotor score on day 1</measure>
    <time_frame>at 24 hours postoperative</time_frame>
    <description>self administrated Net Promotor score: willingness to advise a relative to undergo the same operation on a scale from 0 to 10. Based on the score, patients are divided into promoters (9 or 10), passives (7 or 8), and detractors (under 6). The NPS is determined as follows: NPS = % promoters - % detractors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction score on day 2</measure>
    <time_frame>at 48 hours postoperative</time_frame>
    <description>self administrated Satisfaction score: scale from 0 to 10. A score of &quot;0&quot; meant extremely dissatisfied and that a score of &quot;10&quot; meant extremely satisfied</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction score on day 1</measure>
    <time_frame>at 24 hours postoperative</time_frame>
    <description>self administrated Satisfaction score: scale from 0 to 10. A score of &quot;0&quot; meant extremely dissatisfied and that a score of &quot;10&quot; meant extremely satisfied</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Satisfaction, Patient</condition>
  <arm_group>
    <arm_group_label>Qual'AXI group</arm_group_label>
    <description>patients for whom distal arm surgery was performed under Axillary Brachial Plexus Block</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>perioperative satisfaction assessment</intervention_name>
    <description>Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.</description>
    <arm_group_label>Qual'AXI group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients for whom distal arm surgery was performed under Axillary Brachial Plexus Block in
        a single university hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients for whom distal arm surgery was performed under Axillary Brachial Plexus
             Block

        Exclusion Criteria:

          -  Refusal, inability to consent

          -  inability to fill self-administered survey questionnaire

          -  pregnancy and breastfeeding

          -  surgery &gt; 2 hours

          -  second surgical site requiring anaesthesia or analgesia

          -  chronic use of analgesia (including opioids) or illegal drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Francis Berthier, MD</last_name>
    <phone>0033381218980</phone>
    <email>f1berthier@CHU-besancon.fr</email>
  </overall_contact>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 20, 2020</study_first_submitted>
  <study_first_submitted_qc>March 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2020</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anaesthesia, regional</keyword>
  <keyword>axillary brachial plexus block</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Individual Participant Data (IPD) Sharing Statement depending on the institutional modality under development</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

